apalutamide
Showing 1 - 25 of 62
Darolutamide, Enzalutamide and Apalutamide and How Well These
Not yet recruiting
- Non-metastatic Castration-resistant Prostate Cancer
- Apalutamide
- +2 more
-
Whippany, New JerseyBayer
Aug 25, 2023
Prostate Cancer With =10 Bone Metastases Trial (Apalutamide, 89Sr, Luteinizing Hormone-Releasing Hormone Analog)
Not yet recruiting
- Prostate Cancer With ≤10 Bone Metastases
- Apalutamide
- +2 more
- (no location specified)
Feb 22, 2023
Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)
Not yet recruiting
- Castration-resistant Prostate Cancer
- Apalutamide
- Carotuximab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Sep 6, 2022
Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)
Active, not recruiting
- Prostatic Neoplasms
- Apalutamide
-
Beijing, China
- +3 more
Jan 17, 2023
Called DEAR, to Learn More About Treatment With Darolutamide,
Active, not recruiting
- Non-metastatic Castration-resistant Prostate Cancer
- Darolutamide (Nubeqa, BAY1841788)
- +2 more
-
Whippany, New JerseyBayer
Jan 13, 2023
Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)
Not yet recruiting
- Metastatic Prostate Cancer
- Castration-Sensitive Prostate Cancer
- apalutamide
- +3 more
-
Shanghai, Shanghai, China
- +1 more
Feb 4, 2023
Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))
Not yet recruiting
- Metastatic Castrate-sensitive Prostate Cancer
- Apalutamide
- Androgen-deprivation Therapy (ADT)
-
Lakewood, Colorado
- +5 more
May 23, 2023
Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)
Active, not recruiting
- Prostate Cancer
- Apalutamide
- +3 more
-
Omaha, Nebraska
- +4 more
Nov 10, 2022
Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)
Not yet recruiting
- Metastatic Cancer
- Neoplasm, Prostate
- Abiraterone acetate
- +2 more
-
Bronx, New YorkJames J. Peters VA Medical Center
Jun 16, 2022
Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)
Completed
- Prostate Cancer
- Leuprolide acetate
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022
Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)
Active, not recruiting
- Castration-Resistant Prostate Cancer
- Apalutamide
-
Greenville, South Carolina
- +4 more
Aug 2, 2022
Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)
Recruiting
- Small Cell Neuroendocrine Carcinoma
- +2 more
- Apalutamide
- Cetrelimab
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 21, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,
Completed
- Prostate Adenocarcinoma
- +4 more
- Abiraterone Acetate
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Laboratory Biomarker Analysis, Quality-of-Life Assessment)
Terminated
- Prostate Adenocarcinoma
- Apalutamide
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 28, 2021
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,
Recruiting
- Localized Prostate Carcinoma
- +8 more
- Apalutamide
- Quality-of-Life Assessment
-
Tucson, Arizona
- +4 more
Jun 28, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate
Suspended
- Castration-Resistant Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022
Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)
Recruiting
- Prostate Cancer
- Metastatic Prostate Cancer
- Abiraterone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Feb 21, 2023
Prostatic Tumors Trial in Brazil, Colombia, Mexico (Apalutamide, ADT (Standard of Care))
Available
- Prostatic Neoplasms
- Apalutamide
- ADT (Standard of Care)
-
Florianopolis, Brazil
- +19 more
Aug 2, 2022
Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone
Active, not recruiting
- Metastatic Prostate Carcinoma
- +5 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
High-Risk and Oligometastatic Prostate Cancer Trial (Apalutamide)
Not yet recruiting
- High-Risk and Oligometastatic Prostate Cancer
- Apalutamide
- (no location specified)
Aug 2, 2021
Prostate Cancer Metastatic Trial in Omaha, New York (Apalutamide, Abiraterone acetate, Docetaxel)
Active, not recruiting
- Prostate Cancer Metastatic
- Apalutamide
- +3 more
-
Omaha, Nebraska
- +1 more
Aug 26, 2021